MIST

NASDAQ · Pharmaceuticals

Milestone Pharmaceuticals In

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.22

+0.04 (+3.39%)

As of Aug 8, 10:38 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +3,623.8% upside

Low Target $30.70

Average Target $45.43

High Target $53.70

Current Price $1.22

Current
$1.22

Target
$45.43

$30.70 $45.43 avg $53.70

Scenario Analysis

Bear Case

$30.70

2,416.4%

Low target

Base Case

$45.43

+3,623.8%

Avg target

Bull Case

$53.70

+4,301.6%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$3.06

-60.1% from high

52-Week Low

$1.00

+22.0% from low

Target vs 52W High

$45.43

+1,384.6% vs high

Next Earnings Report

Aug 12, 2026 · Before Market Open

until earnings

EPS Est: $-0.20

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%